Patents Assigned to Ben-Gurion University of the Negev
-
Patent number: 9977018Abstract: An electrochemical lateral flow biosensor (ELFB) includes an ELFB strip and electronic detector unit coupled to the strip. The strip includes a polymeric hydrophobic membrane, conjugation pad, sampling pad, screen-printed electrode (SPE), and wick pad. The membrane provides a solid support and enables capillary flow along the strip. The conjugation pad is placed on the membrane at one end of the strip and contains adsorbed dehydrated labelled conjugate particles that are coated with the biorecognition element and coated or filled with the electrochemically active component. The sampling pad is placed on the conjugation pad and provides adsorption of the liquid sample. The SPE is coated with immobilized capture antibodies. The wick pad is placed on the SPE and provides absorption of excess reagents maintaining a lateral flow along the strip. The ELFB can be used for rapid and early detection and quantity analysis of biological liquids and wastewater.Type: GrantFiled: April 14, 2014Date of Patent: May 22, 2018Assignees: NANYANG TECHNOLOGICAL UNIVERSITY, BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: Robert S. Marks, Polina Brangel, Vladislav Papper, Evgeni Eltzov
-
Patent number: 9934388Abstract: A method for encrypting a database, according to which a dedicated encryption module is placed inside a Database Management Software above a database cache. Each value of the database is encrypted together with the coordinates of said value using a dedicated encryption method, which assumes the existence of an internal cell identifier that can be queried but not tampered.Type: GrantFiled: February 16, 2015Date of Patent: April 3, 2018Assignee: Ben-Gurion University of the Negev Research and Development AuthorityInventors: Yuval Elovici, Ronen Vaisenberg, Erez Shmueli
-
Patent number: 9906189Abstract: A method for increasing the power extraction capability out of Differential Power Processor (DPP) system, which consists of a chain of N serially connected PV elements and an array of N?1 gyrator-type converters which are current sourcing resonant Switched Capacitor Converters (SCCs), each of which being connected in parallel with two adjacent PV elements. Accordingly, local MPPT is continuously performed, by each gyrator-type converter, to one of its two connected PV elements by sinking or sourcing current to/from the neighboring PV element. Whenever a mismatch in the MPPs is detected, the gyrator-type converters are used to provide the difference in current that is required for each of the PV elements to operate at its MPP, such that the amount of power processed by each gyrator-type converter in the chain is linearly proportional to its location in the chain, with respect to the mismatched PV element.Type: GrantFiled: August 5, 2013Date of Patent: February 27, 2018Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH & DEVELOPMENT AUTHORITYInventors: Shmuel Ben-Yaakov, Alon Cervera, Alon Blumenfeld, Mor Mordechai Peretz
-
Patent number: 9867884Abstract: The site-specific expression of selectins on endothelial cells of blood vessels during angiogenesis provides an opportunity to target anti-cancer drugs to the vascular endothelium to extend the range of the therapeutic effect. This invention describes an innovative drug targeting strategy for the selective delivery of the anticancer drugs to endothelial cells by means of polymer-drug conjugates modified with a carbohydrate ligand for the vascular selectins. A model chemotherapeutic drug, doxorubicin, and the E-selectin ligand, sLex, are attached to a biocompatible polymer (HPMA). The selective binding, cellular uptake, intracellular fate, and cell cytotoxicity of the polymer-bound drug are investigated in human endothelial cells.Type: GrantFiled: August 19, 2014Date of Patent: January 16, 2018Assignee: Ben-Gurion University of Negev Research & Development AuthorityInventors: Ayelet David, Gonen Ashkenasy, Yosi Shamay
-
Patent number: 9861686Abstract: The present invention provides a method of treating, delaying the onset, delaying progression of, reducing the incidence of or reducing the severity of amyotrophic lateral sclerosis in a subject, the method comprising administering to a subject an agent, which interferes with IgG-A2BG2 expression, IgG-A2BG2 function or IgG-A2BG2 interaction with CD16 in said subject.Type: GrantFiled: December 4, 2012Date of Patent: January 9, 2018Assignee: Ben-Gurion University of the Negev Research & Development AuthorityInventors: Angel Porgador, Rachel Lichtenstein
-
Patent number: 9844336Abstract: An embodiment of the invention provides a method of diagnosing obstructive sleep apnea, the method comprising: acquiring a sleep sound signal comprising sounds made by a person during sleep; detecting a plurality of snore sounds in the sleep sound signal; determining a set of mel-frequency cepstral coefficients for each of the snore sounds; determining a characterizing feature for the sleep sound signal responsive to a sum of the variances of the cepstral coefficients; and using the characterizing feature to diagnose obstructive sleep apnea in the person.Type: GrantFiled: August 24, 2011Date of Patent: December 19, 2017Assignees: Ben Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.Inventors: Yaniv Zigel, Ariel Tarasiuk, Nir Ben Israel
-
Publication number: 20170328895Abstract: An isolated peptide is disclosed. The peptide comprises a titanium oxide binding amino acid sequence connected to a heterologous biologically active amino acid sequence via a beta sheet breaker linker, wherein: (i) the titanium oxide binding amino acid sequence is selected to bind coordinatively with titanium oxide; (ii) the titanium oxide binding amino acid sequence is selected to induce a beta sheet structure; and (ii) the titanium oxide binding amino acid sequence binds to titanium oxide with a higher affinity than said biologically active amino acid sequence binds to the titanium oxide under physiological conditions. Use of the peptides and titanium devices comprising same are also disclosed.Type: ApplicationFiled: August 3, 2017Publication date: November 16, 2017Applicant: Ben-Gurion University of the Negev Research and Development AuthorityInventors: Hanna RAPAPORT, Anna GITTELMAN
-
Patent number: 9802989Abstract: An isolated novel oil globule protein encoded by a polynucleotide sequence is provided together with a composition which includes the isolated protein. A transgenic organism transformed by a polynucleotide encoding a protein which at least partially comprises the amino acid sequence of the novel oil globule protein is also provided. The invention also provides a method for producing or enhancing the production of a carotenoid such as astaxanthin, which is an oil globule constituent.Type: GrantFiled: August 30, 2011Date of Patent: October 31, 2017Assignees: Ben Gurion University of the Negev Research and Development Authority, Yeda Research and Development Co. Ltd. at the Weizmann Institute of ScienceInventors: Sammy Boussiba, Ehud Peled, Uri Pick, Aliza Zarka, Stefan Lou, Meira Weiss
-
Patent number: 9731048Abstract: An isolated peptide is disclosed. The peptide comprises a titanium oxide binding amino acid sequence connected to a heterologous biologically active amino acid sequence via a beta sheet breaker linker, wherein: (i) the titanium oxide binding amino acid sequence is selected to bind coordinatively with titanium oxide; (ii) the titanium oxide binding amino acid sequence is selected to induce a beta sheet structure; and (ii) the titanium oxide binding amino acid sequence binds to titanium oxide with a higher affinity than said biologically active amino acid sequence binds to the titanium oxide under physiological conditions. Use of the peptides and titanium devices comprising same are also disclosed.Type: GrantFiled: June 3, 2013Date of Patent: August 15, 2017Assignee: Ben-Gurion University of the Negev Research and Development AuthorityInventors: Hanna Rapaport, Anna Gittelman
-
Patent number: 9731046Abstract: The present invention provides a multi-compartment hydrogel, and a sulfated polysaccharide and at least two bioactive polypeptides capable of binding said sulfated polysaccharide, for use in repair or regeneration of a damaged tissue in a mammal. Also provided is a method for constructing the multi-compartment hydrogel. The present invention also provides a method for the repair or regeneration of a damaged tissue in a mammal, and a kit for constructing a multi-compartment hydrogel.Type: GrantFiled: February 21, 2013Date of Patent: August 15, 2017Assignee: Ben Gurion University of the Negev Research and Development AuthorityInventors: Smadar Cohen, Tali Re'Em, Emil Ruvinov
-
Patent number: 9721691Abstract: The present invention provides a method for producing molybdenum-99 comprising: i) providing an electron accelerator; ii) providing a molybdenum converter/target unit (Mo-CTU) comprising one or more metallic components, wherein each one of said metallic components is made of a material selected from the group consisting of natural molybdenum, molybdenum-100, molybdenum-98, and mixtures thereof; iii) directing an electron beam generated via said electron accelerator onto said Mo-CTU to produce a braking radiation (bremsstrahlung); iv) employing said bremsstrahlung onto said Mo-CTU to produce molybdenum-99 and neutrons via a photo-neutron reaction; v) slowing down the neutrons produced in step iv) with a low atomic liquid, e.g. distilled water; and optionally vi) employing the neutrons produced in step iv) to produce a complementary amount of molybdenum-99 via a neutron capture reaction on said Mo-CTU. The invention further provides an apparatus for producing molybdenum-99.Type: GrantFiled: August 22, 2012Date of Patent: August 1, 2017Assignee: Ben-Gurion University of the Negev, Research and Development AuthorityInventor: Alexander Tsechanski
-
Patent number: 9718849Abstract: Sulfur chelated ruthenium compounds represented by the following formula: wherein M indicates the ruthenium metal bound to a benzylidene carbon; R represents C1-C7 alkyl group or optionally substituted aryl; X1 and X2 each independently represent halogen; Y1 and Y2 each independently denote unsubstituted or alkyl-substituted phenyl; and Z independently represents hydrogen, electron withdrawing or electron donating substituent, with m being an integer from 1 to 4, and processes and compositions related thereto.Type: GrantFiled: July 18, 2013Date of Patent: August 1, 2017Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: N. Gabriel Lemcoff, Amos Ben-Asuly
-
Patent number: 9711253Abstract: A radiotherapy system is disclosed. The radiotherapy system comprises an electron beam generator for generating an electron beam and a magnetic field generator for generating a magnetic field. In some embodiments of the present invention, the system further comprises a controller for controlling the electron beam and the magnetic field generators such that the electron beam is dynamically shifted and the magnetic field is dynamically redirected synchronously with the shifting.Type: GrantFiled: November 28, 2011Date of Patent: July 18, 2017Assignees: Tel HaShomer Medical Research Infrastructure and Services Ltd., Ben-Gurion University of the Negev Research and Development AuthorityInventors: Dror Alezra, Eran Nardi, Sion Koren, Itzhak Orion
-
Patent number: 9670139Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.Type: GrantFiled: December 17, 2013Date of Patent: June 6, 2017Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak
-
Patent number: 9670138Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.Type: GrantFiled: November 12, 2013Date of Patent: June 6, 2017Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventor: Esther Priel
-
Patent number: 9670249Abstract: The present invention relates in general to the field of tissue engineering and more specifically to amphiphilic peptides and peptide matrices thereof useful in vitro and in situ biomineralization and inducing bone repair. The present invention provides peptides, which are useful in hydrogels and other pharmaceutical compositions, and methods and kits of use for bone repair and promotion of biomineralization. Certain hydrogels according to the invention comprise cells within or adhered to the peptide matrix.Type: GrantFiled: January 14, 2014Date of Patent: June 6, 2017Assignee: Ben-Gurion University of the Negev Research and Development AuthorityInventor: Hanna Rapaport
-
Patent number: 9663448Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.Type: GrantFiled: November 1, 2013Date of Patent: May 30, 2017Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: Esther Priel, Aviv Gazit, Shimon Slavin, Sara Yitzchak
-
Patent number: 9649598Abstract: The invention provides a process for purifying water containing soluble species capable of forming one or more sparingly soluble salts or minerals, said process comprising feeding a pressurized water stream into a treatment zone having one or more membranes disposed therein, passing said stream along said membrane(s) to recover a permeate and to withdraw a concentrate therefrom while periodically reversing the direction of the flow of said stream in said treatment zone, wherein the periodicity of the flow reversal is such that said one or more membranes are exposed to supersaturation conditions evolving in said water stream for a period of time which is less then the time required for said supersaturated water stream to precipitate one or more of said sparingly soluble salts and/or minerals therefrom.Type: GrantFiled: February 28, 2012Date of Patent: May 16, 2017Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITYInventors: Jack Gilron, Eliyahu Korin
-
Patent number: 9642803Abstract: Nano-sized particles are provided comprising at least one multi-headed amphiphilic compound, in which at least one headgroup of said multi-headed amphiphilic compound is selectively cleavable or contains a selectively cleavable group, and at least one biologically active agent, which is both encapsulated within the nano-particle and non-covalently associated thereto.Type: GrantFiled: May 4, 2010Date of Patent: May 9, 2017Assignee: Ben-Gurion University Of The Negev Research And Development AuthorityInventors: Charles Linder, Sarina Grinberg, Eliahu Heldman
-
Patent number: 9597001Abstract: This invention provides a fully automatic method and a system for detecting and classifying cardiac arrhythmias from a surface ECG record. The method defines four relevant parameters whose values are extracted from said ECG record. Clinically relevant conclusions are assigned to various combinations of the obtained values of said parameters. The method can be employed for detecting fetal QRS complexes from abdomen ECG of a pregnant woman.Type: GrantFiled: August 20, 2013Date of Patent: March 21, 2017Assignee: Ben-Gurion University of the Negev Research & Development AuthorityInventors: Yaniv Zigel, Amos Katz, Or Perlman, Nahum Noam Weisman